Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of Mogamulizumab + Nivolumab in Advanced Solid Tumors
jRCT2080222879Phase 1Completed
- Sponsor
- Kyowa Kirin
- Start
- Jun 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 1, open-label, single-arm trial of mogamulizumab and nivolumab in Nonhematologic neoplasms and solid tumor, sponsored by Kyowa Kirin. Started Jun 2015; status: completed.
02
Drugs
mogamulizumabnivolumab
03
Conditions
Nonhematologic neoplasmssolid tumor
Beyond the preview
Go deeper on jRCT2080222879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222879.